{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:18:21Z","timestamp":1784225901614,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T00:00:00Z","timestamp":1348099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.2119\/molmed.2012.00008","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T16:47:24Z","timestamp":1358354844000},"page":"1387-1401","source":"Crossref","is-referenced-by-count":119,"title":["Pigment Epithelium-Derived Factor (PEDF) Peptide Eye Drops Reduce Inflammation, Cell Death and Vascular Leakage in Diabetic Retinopathy in Ins2Akita Mice"],"prefix":"10.1186","volume":"18","author":[{"given":"Yanling","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan Franco","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corban","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anzor","family":"Grivitishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.","family":"Barnstable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Tombran-Tink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,20]]},"reference":[{"key":"18101387_CR1","first-page":"417","volume":"8","author":"NA Calcutt","year":"2009","unstructured":"Calcutt NA, Cooper ME, Kern TS, Schmidt AM. (2009) Therapies for hyperglycaemic-induced diabetic complications: from animal models to clinical trials. Nat. Rev. 8:417\u201329.","journal-title":"Nat. Rev."},{"key":"18101387_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1172\/JCI2425","volume":"102","author":"AJ Barber","year":"1998","unstructured":"Barber AJ, et al. (1998) Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J. Clin. Invest. 102:783\u201391.","journal-title":"J. Clin. Invest."},{"key":"18101387_CR3","first-page":"145","volume":"144","author":"TM Scott","year":"1986","unstructured":"Scott TM, Foote J, Peat B, Galway G. (1986) Vascular and neural changes in the rat optic nerve following induction of diabetes with streptozotocin. J. Anat. 144:145\u201352.","journal-title":"J. Anat."},{"key":"18101387_CR4","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1167\/iovs.04-1340","volume":"46","author":"AJ Barber","year":"2005","unstructured":"Barber AJ, et al. (2005) The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest. Ophthalmol. Vis. Sci. 46:2210\u20138.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"18101387_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMra021678","volume":"350","author":"RN Frank","year":"2004","unstructured":"Frank RN. (2004) Diabetic retinopathy. N. Engl. J. Med. 350:48\u201358.","journal-title":"N. Engl. J. Med."},{"issue":"Suppl.2","key":"18101387_CR6","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.1016\/S0039-6257(02)00387-9","volume":"47","author":"TW Gardner","year":"2002","unstructured":"Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW. (2002) Diabetic retinopathy: more than meets the eye. Surv. Ophthalmol. 47(Suppl. 2):S253\u201362.","journal-title":"Surv. Ophthalmol."},{"key":"18101387_CR7","first-page":"386","volume":"8","author":"DA Sandoval","year":"2009","unstructured":"Sandoval DA, Obici S, Seeley RJ. (2009) Targeting the CNS to treat type 2 diabetes. Nat. Rev. 8:386\u201398.","journal-title":"Nat. Rev."},{"key":"18101387_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nm0110-40","volume":"16","author":"C Rask-Madsen","year":"2010","unstructured":"Rask-Madsen C, King Gl. (2010) Kidney complications: factors that protect the diabetic vasculature. Nat. Med. 16:40\u20131.","journal-title":"Nat. Med."},{"key":"18101387_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1534","volume":"13","author":"BB Gao","year":"2007","unstructured":"Gao BB, et al. (2007) Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 13:181\u20138.","journal-title":"Nat. Med."},{"key":"18101387_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nm0207-131","volume":"13","author":"TW Gardner","year":"2007","unstructured":"Gardner TW, Antonetti DA. (2007) A prize catches for diabetic retinopathy. Nat. Med. 13:131\u20132.","journal-title":"Nat. Med."},{"key":"18101387_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1172\/JCI19478","volume":"113","author":"J Ruberte","year":"2004","unstructured":"Ruberte J, et al. (2004) Increased ocular levels of IGF-1 in transgenic mice leads to diabetes-like eye disease. J. Clin. Invest. 113:1149\u201357.","journal-title":"J. Clin. Invest."},{"key":"18101387_CR12","doi-asserted-by":"publisher","first-page":"20213","DOI":"10.1074\/jbc.M602110200","volume":"281","author":"S Yamagishi","year":"2006","unstructured":"Yamagishi S, et al. (2006) Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J. Biol. Chem. 281:20213\u201320.","journal-title":"J. Biol. Chem."},{"key":"18101387_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/jme.1.02008","volume":"37","author":"SX Zhang","year":"2006","unstructured":"Zhang SX, Wang JJ, Gao G, Parke K, Ma JX. (2006) Pigment epithelium-derived factor down-regulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J. Mol. Endocrinol. 37:1\u201312.","journal-title":"J. Mol. Endocrinol."},{"key":"18101387_CR14","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1073\/pnas.031252398","volume":"98","author":"V Stellmach","year":"2001","unstructured":"Stellmach V, Crawford S, Zhou W, Bouck N. (2001) Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc. Natl. Acad. Sci. U. S. A. 98:2593\u20137.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"18101387_CR15","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.2337\/diabetes.47.12.1953","volume":"47","author":"DA Antonetti","year":"1998","unstructured":"Antonetti DA, et al. (1998) Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells: Penn State Retina Research Group. Diabetes 47:1953\u20139.","journal-title":"Diabetes"},{"key":"18101387_CR16","doi-asserted-by":"publisher","first-page":"23463","DOI":"10.1074\/jbc.274.33.23463","volume":"274","author":"DA Antonetti","year":"1999","unstructured":"Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW. (1999) Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1: a potential mechanism for vascular permeability in diabetic retinopathy and tumors. J. Biol. Chem. 274:23463\u20137.","journal-title":"J. Biol. Chem."},{"key":"18101387_CR17","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/nm.2052","volume":"15","author":"P Geraldes","year":"2009","unstructured":"Geraldes P, et al. (2009) Activation of PKC-delta dn SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat. Med. 15:1298\u2013306.","journal-title":"Nat. Med."},{"key":"18101387_CR18","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.1073\/pnas.0800454105","volume":"105","author":"Z Tong","year":"2008","unstructured":"Tong Z, et al. (2008) Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc. Natl. Acad. Sci. U. S. A. 105:6998\u20137003.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"18101387_CR19","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.1073\/pnas.1236929100","volume":"100","author":"R Tamarat","year":"2003","unstructured":"Tamarat R, et al. (2003) Blockage of advanced glycation end-product formation restores ischemiainduced angiogenesis in diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 100:8555\u201360.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"18101387_CR20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/nature04482","volume":"438","author":"RF Gariano","year":"2005","unstructured":"Gariano RF, Gardner TW. (2005) Retinal angiogenesis in development and disease. Nature. 438:960\u20136.","journal-title":"Nature"},{"key":"18101387_CR21","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nm1109-1248","volume":"15","author":"DA Antonetti","year":"2009","unstructured":"Antonetti DA. (2009) Eye vessels saved by rescuing their pericyte partners. Nat. Med. 15:1248\u20139.","journal-title":"Nat. Med."},{"key":"18101387_CR22","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrn1176","volume":"4","author":"J Tombran-Tink","year":"2003","unstructured":"Tombran-Tink J, Barnstable CJ. (2003) PEDF: a multifaceted neurotrophic factor. Nat. Rev. Neurosci. 4:628\u201336.","journal-title":"Nat. Rev. Neurosci."},{"key":"18101387_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1471-4914(03)00074-1","volume":"9","author":"J Tombran-Tink","year":"2003","unstructured":"Tombran-Tink J, Barnstable CJ. (2003) Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor. Trends Mol. Med. 9:244\u201350.","journal-title":"Trends Mol. Med."},{"key":"18101387_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.exer.2006.04.014","volume":"83","author":"H Li","year":"2006","unstructured":"Li H, et al. (2006) A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres. Exp. Eye. Res. 83:824\u201333.","journal-title":"Exp. Eye. Res."},{"key":"18101387_CR25","doi-asserted-by":"publisher","first-page":"e15056","DOI":"10.1371\/journal.pone.0015056","volume":"5","author":"AG Gvritishvili","year":"2010","unstructured":"Gvritishvili AG, Leung, KW, Tombran-Tink J. (2010) Codon preference optimization increases heterologous PEDF expression. PLoS One. 5:e15056.","journal-title":"PLoS One"},{"key":"18101387_CR26","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1158\/1078-0432.CCR-08-2113","volume":"15","author":"Y Mirochnik","year":"2009","unstructured":"Mirochnik Y, Aurora A, Schulze-Hoepfner FT, Deabes A. (2009) Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth. Clin. Cancer Res. 15:1655\u201363.","journal-title":"Clin. Cancer Res."},{"key":"18101387_CR27","doi-asserted-by":"publisher","first-page":"9378","DOI":"10.1523\/JNEUROSCI.22-21-09378.2002","volume":"22","author":"MM Bilak","year":"2002","unstructured":"Bilak MM, et al. (2002) Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons. J. Neurosci. 22:9378\u201386.","journal-title":"J. Neurosci."},{"key":"18101387_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrn2294","volume":"9","author":"DR Tomlinson","year":"2008","unstructured":"Tomlinson DR, Gardine NJ. (2008) Glucose neurotoxicity. Nat. Rev. Neurosci. 9:36\u201345.","journal-title":"Nat. Rev. Neurosci."},{"key":"18101387_CR29","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1096\/fj.01-0253hyp","volume":"15","author":"T Purves","year":"2001","unstructured":"Purves T, et al. (2001) A role for mitogen-activated protein kinases in the aetiology of diabetic neuropathy. FASEB J. 15:2508\u201314.","journal-title":"FASEB J."},{"key":"18101387_CR30","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s001250051439","volume":"42","author":"DR Tomlinson","year":"1999","unstructured":"Tomlinson DR. (1999) Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia. 42:1271\u201381.","journal-title":"Diabetologia"},{"key":"18101387_CR31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/cr.2008.37","volume":"18","author":"MC Lawrence","year":"2008","unstructured":"Lawrence MC, et al. (2008) The roles of MAPKs in disease. Cell Res. 18:436\u201342.","journal-title":"Cell Res."},{"key":"18101387_CR32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/eye.1993.58","volume":"7","author":"A Garner","year":"1993","unstructured":"Garner A. (1993) Histopathology of diabetic retinopathy in man. Eye. 7:250\u20133.","journal-title":"Eye."},{"key":"18101387_CR33","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2337\/diacare.15.5.620","volume":"15","author":"MA Leo Di","year":"1992","unstructured":"Di Leo MA, et al. (1992) Nonselective loss of contrast sensitivity in visual system testing in early type I diabetes. Diabetes Care. 15:620\u20135.","journal-title":"Diabetes Care"},{"key":"18101387_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/BF00220704","volume":"234","author":"AA Dosso","year":"1996","unstructured":"Dosso AA, et al. (1996) Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch. Clin. Exp. Ophthalmol. 234:300\u20135.","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"18101387_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/bjo.80.3.209","volume":"80","author":"A Harris","year":"1996","unstructured":"Harris A, et al. (1996) Hyperoxia improves contrast sensitivity in early diabetic retinopathy. Br. J. Ophthalmol. 80:209\u201313.","journal-title":"Br. J. Ophthalmol."},{"key":"18101387_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/bjo.76.8.461","volume":"76","author":"KJ Hardy","year":"1992","unstructured":"Hardy KJ, Lipton J, Scase MO, Foster DH, Scarpello JH. (1992) Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. Br. J. Ophthalmol. 76:461\u20134.","journal-title":"Br. J. Ophthalmol."},{"key":"18101387_CR37","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/bjo.78.10.754","volume":"78","author":"KJ Hardy","year":"1994","unstructured":"Hardy KJ, Scarpello JH, Foster DH, Moreland JD. (1994) Effect of diabetes associated increases in lens optical density on colour discrimination in insulin dependent diabetes. Br. J. Ophthalmol. 78:754\u20136.","journal-title":"Br. J. Ophthalmol."},{"key":"18101387_CR38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/bjo.70.5.330","volume":"70","author":"GB Arden","year":"1986","unstructured":"Arden GB, et al. (1986) Pattern electroretinograms become abnormal when background diabetic retinopathy deteriorates to a preproliferative stage: possible use as a screening test. Br. J. Ophthalmol. 70:330\u20135.","journal-title":"Br. J. Ophthalmol."},{"key":"18101387_CR39","first-page":"1971","volume":"41","author":"E Rungger-Br\u00e4ndle","year":"2000","unstructured":"Rungger-Br\u00e4ndle E, Dosso AA, Leuenberger PM. (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 41:1971\u201380.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"18101387_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS. (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosc. 8:57\u201369.","journal-title":"Nat. Rev. Neurosc."},{"key":"18101387_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0165-5728(90)90094-4","volume":"30","author":"A Suzumura","year":"1990","unstructured":"Suzumura A, Sawada M, Yamamoto H, Marunouchi T. (1990) Effects of colony stimulating factors on isolated microglia in vitro. J. Neuroimmunol. 30:111\u201320.","journal-title":"J. Neuroimmunol."},{"key":"18101387_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/glia.10118","volume":"40","author":"A Basu","year":"2002","unstructured":"Basu A, Krady JK, Enterline JR, Levison SW. (2002) Transforming growth factor beta1 prevents IL-1beta-induced microglial activation, whereas TNFalpha- and IL-6-stimulated activation are not antagonized. Glia. 40:109\u201320.","journal-title":"Glia."},{"key":"18101387_CR43","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1189\/jlb.0207114","volume":"81","author":"T Langmann","year":"2007","unstructured":"Langmann T. (2007) Microglia activation in retinal degeneration. J. Leukoc. Biol. 81:1345\u201351.","journal-title":"J. Leukoc. Biol."},{"key":"18101387_CR44","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.neuroscience.2003.08.043","volume":"122","author":"M Sayyah","year":"2003","unstructured":"Sayyah M, Javad-Pour M, Ghazi-Khansari M. (2003) The bacterial endotoxin lipopolysaccha-ride enhances seizure susceptibility in mice: involvement of proinflammatory factors: nitric oxide and prostaglandins. Neuroscience. 122:1073\u201380.","journal-title":"Neuroscience"},{"key":"18101387_CR45","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S0161-6420(95)30901-3","volume":"102","author":"AP Adamis","year":"1995","unstructured":"Adamis AP, D\u2019Amato RJ. (1995) Shedding light on diabetic retinopathy. Ophthalmology. 102:1127\u20138.","journal-title":"Ophthalmology"},{"key":"18101387_CR46","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1073\/pnas.96.17.9879","volume":"96","author":"HD Venters","year":"1999","unstructured":"Venters HD, et al. (1999) A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc. Natl. Acad. Sci. U. S. A. 96:9879\u201384.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"18101387_CR47","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1210\/en.2004-0246","volume":"145","author":"WH Shen","year":"2004","unstructured":"Shen WH, et al. (2004) Tumor necrosis factor alpha inhibits insulin-like growth factor I-induced hematopoietic cell survival and proliferation. Endocrinology. 145:3101\u20135.","journal-title":"Endocrinology"},{"key":"18101387_CR48","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","volume":"6","author":"C Sims-Robinson","year":"2010","unstructured":"Sims-Robinson C, Kim B, Rosko A, Feldman EL. (2010) How does diabetes accelerate Alzheimer disease pathology? Nat. Rev. Neurol. 6:551\u20139.","journal-title":"Nat. Rev. Neurol."},{"key":"18101387_CR49","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner JR. (2009) Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9:799\u2013809.","journal-title":"Nat. Rev. Immunol."},{"key":"18101387_CR50","doi-asserted-by":"publisher","first-page":"31263","DOI":"10.1074\/jbc.M111.238147","volume":"286","author":"T Suzuki","year":"2011","unstructured":"Suzuki T, Yoshinaga N, Tanabe S. (2011) Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J. Biol. Chem. 286:31263\u201371.","journal-title":"J. Biol. Chem."},{"key":"18101387_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1385\/CBB:44:1:157","volume":"44","author":"AL Seynhaeve","year":"2006","unstructured":"Seynhaeve AL, Vermeulen CE, Eggermont AM, ten Hagen TL. (2006) Cytokines and vascular permeability: an in vitro study on human endothelial cells in relation to tumor necrosis factor-alpha-primed peripheral blood mononuclear cells. Cell. Biochem. Biophys. 44:157\u201369.","journal-title":"Cell. Biochem. Biophys."},{"key":"18101387_CR52","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.4049\/jimmunol.153.9.3967","volume":"153","author":"L Li","year":"1994","unstructured":"Li L, Elliott JF, Mosmann TR. (1994) IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J. Immunol. 153:3967\u201378.","journal-title":"J. Immunol."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2012.00008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2012.00008\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/molmed.2012.00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2012.00008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T18:46:05Z","timestamp":1687977965000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2012.00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,20]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["18101387"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2012.00008","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,20]]}}}